Ultragenyx Pharmaceutical | Resultat Før Skat

Name: Ultragenyx Pharmaceutical | Resultat Før Skat
Creator: TRADING ECONOMICS
License: https://creativecommons.org/licenses/by/4.0/

width

height

	Pre Tax Profit		Dato
Acadia Pharmaceuticals ACAD:US	$ -66.34M	18.52M	2020-12
Acceleron Pharma XLRN:US	$ -57.4M	18.17M	2020-12
Agios Pharmaceuticals AGIO:US	$ -97.66M	1.32M	2020-12
Alexion Pharmaceuticals ALXN:US	$ 775.5M	86.4M	2020-12
Alnylam Pharmaceuticals ALNY:US	$ -243.6M	8.85M	2020-12
Aptinyx Inc APTX:US	$ -11338000	1.18M	2020-09
Biomarin Pharmaceutical BMRN:US	$ -40.18M	21.03M	2020-12
Bluebird Bio BLUE:US	$ -199.62M	5.2M	2020-12
Epizyme EPZM:US	$ -66.12M	10.05M	2020-12
Esperion Therapeutics ESPR:US	$ -104476000	19.04M	2020-12
Insmed INSM:US	$ -101592000	38.25M	2020-12
IONIS PHARMACEUT IONS:US	$ 66M	106M	2020-12
Karyopharm Therapeutics KPTI:US	$ -43359000	10.09M	2020-12
Macrogenics MGNX:US	$ -2.09M	33.96M	2020-12
Neurocrine Biosciences NBIX:US	$ 60.1M	117.2M	2020-12
Ptc Therapeutics PTCT:US	$ -61.72M	14.32M	2020-12
Regeneron Pharmaceuticals REGN:US	$ 1170.8M	22.9M	2020-12
Ultragenyx Pharmaceutical RARE:US	$ 55.16M	123.69M	2020-12
Vertex Pharmaceuticals VRTX:US	$ 858.3M	6.27M	2020-12
Vital Therapies VTL:US	$ -11.16M	1.75M	2020-12
Xoma XOMA:US	$ -1.08M	2.46M	2020-09

Ultragenyx Pharmaceutical Resultat Før Skat - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Mar 2021.